Should I buy Universal Health Services (UHS) stock or is it too late?

Universal Health Services · Health Care · price $179

See the full Universal Health Services (UHS) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (830 calls tested). It aims for $191 (+6.7 %), call made on July 30, 2026, maturing on July 30, 2027 (76 d ago).

The 6 reliable analysts $190+5.8 %

The 5 other firms $194+8.4 %

How to read it: the 6 reliable firms are not filtered by optimism — 4 aim above the price, 2 below, hence their $190 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Universal Health Services

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
B of A Securities	80 %	+15.9 %	10	$185 +3%
JP Morgan	60 %	+15.5 %	5	$195 +9%
Barclays	57 %	+10.1 %	21	$168 -6%
UBS	54 %	+3.7 %	13	$310 +73%
Wells Fargo	54 %	-0.2 %	13	$166 -7%
Goldman Sachs	50 %	-2.6 %	12	$190 +6%
Cantor Fitzgerald	44 %	-9.1 %	9	$194 +8%
Credit Suisse	88 %	+27.2 %	17	—

In short — Should you invest in Universal Health Services? Is it too late, still worth it? Analysts are split (36% buy, median target $190, i.e. +6%), and the most reliable on UHS targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on UHS, TD Cowen (67% hit rate, 3 scored calls), targets $197 (call made on June 22, 2026, maturing on June 22, 2027) (+10%) in its most recent call, and $245 (call made on January 7, 2026, maturing on January 7, 2027) (+37%) in the one coming due soonest.
Reasonable valuation (P/E ~7) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 11 ratings, 7 are neutral.
Limited upside: the median target is only +6% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on UHS

Median target $190 (+6%) · 11 ratings · Hold consensus

Strong Buy00%

Buy436%

Hold764%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Universal Health Services now?

We won't decide for you. The facts: 36% of analysts rate it a buy, median target $190 (+6%), and TD Cowen (most reliable on UHS, 67%) targets $197. Weigh that against valuation (P/E ~7). This is not personalized advice.

Is it too late to invest in Universal Health Services?

Not according to analysts: the median target ($190) is still +6% above the current price ($179) (most reliable on UHS: TD Cowen, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Universal Health Services still worth investing in?

It depends on the gap between the price ($179) and its estimated value: analysts target $190 on median (+6%), with 36% buys (most reliable on UHS: TD Cowen, 67%). Cross-check with their real reliability on UHS and the cautions above. Information, not advice.

What's the main risk in buying UHS?

The consensus is not unanimous: of 11 ratings, 7 are neutral.

→ Go deeper: the full Universal Health Services profile (consensus, analyst reliability, price target, performance).